Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study

Published:2021-12-07 Issue:1 Volume:11 Page:139-150
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Tawbi Hussein¹^ORCID,To Tu My²,Bartley Karen²,Sadetsky Natalia²,Burton Elizabeth¹³,Haydu Lauren³^ORCID,McKenna Edward²

Affiliation:

1. Department of Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Genentech, Inc. South San Francisco California USA

3. Department of Surgical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4438

Reference33 articles.

1. Determinants of Outcome in Melanoma Patients With Cerebral Metastases

2. Melanoma central nervous system metastases: current approaches, challenges, and opportunities

3. Prognostic factors for survival in melanoma patients with brain metastases

4. Treatment of Melanoma CNS Metastases

5. Clinical Management of Multiple Melanoma Brain Metastases

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the Complexities of Brain Metastases Management;American Society of Clinical Oncology Educational Book;2024-06

2. Enrollment Trends Among Patients with Melanoma Brain Metastasis in Active Clinical Trials;Cancer Investigation;2024-05-22

3. Brain tumor induce immunoregulatory dendritic cells in tumor draining lymph nodes that can be targeted by OX40;2024-04-02

4. Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey;Melanoma Research;2024-03-28

5. POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis;Neuro-Oncology Advances;2024-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3